SCHEMBL9968477

SCHEMBL9968477

CCC(=O)c1cc(S(=O)(=O)NCc2ccc(O)c(O)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
SLC12A2 P55011 1/20 0.43
SLC12A5 Q9H2X9 1/20 0.43
VCAM1 P19320 2/20 0.43
CYP19A1 P11511 3/20 0.43
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
SNCA P37840 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 3/20 0.40
MAPK1 P28482 3/20 0.40
POLB P06746 2/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9968476 0.89 ALDH1A1 (0.47) ALDH1A1LMNAGAAMAPTSLC12A2
SCHEMBL9968618 0.84 KMT2A (0.47) ALDH1A1LMNAMAPTCYP19A1KDM4E
SCHEMBL9942828 0.83 POLB (0.55) ALDH1A1LMNAMAPTCYP1A2CYP3A4
SCHEMBL9968569 0.78 MAPK1 (0.44) ALDH1A1LMNAMAPTKDM4EMAPK1
SCHEMBL9941200 0.72 POLB (0.59) ALDH1A1LMNAMAPTCYP1A2CYP3A4
SCHEMBL4273160 0.70 HSP90AB1 (0.54) ALDH1A1LMNAGAAMAPTCA1
SCHEMBL9968581 0.69 KDM4E (0.43) ALDH1A1LMNAMAPTCYP19A1KDM4E
SCHEMBL27400561 0.67 GPR35 (0.51) ALDH1A1LMNAMAPTCYP1A2KDM4E
SCHEMBL13657380 0.67 TSHR (0.55) ALDH1A1LMNAMAPTCYP3A4MAPK1
SCHEMBL6078727 0.67 CYP19A1 (0.50) LMNAMAPTCYP19A1CA2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012082862-A2 ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF BETH ISRAEL DEACONESS MEDICAL CENTER (US) 2012-06-21 WO disclosed